Codexis Logo - September 2023.png
Codexis to Participate in 35th Annual Piper Sandler Healthcare Conference
November 14, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the 35th Annual Piper Sandler...
Codexis Logo - September 2023.png
Codexis Reports Third Quarter 2023 Financial Results
November 02, 2023 16:05 ET | Codexis, Inc.
Company Remains on Track to Demonstrate Gram-Scale Synthesis with ECO Synthesis™ Platform for RNAi Therapeutics Production by End of Year Strong Financial Position Enables Projected Runway to...
Codexis Logo - September 2023.png
Codexis to Participate in Upcoming Healthcare Conferences
October 31, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that management will participate in four upcoming investor...
Codexis Logo - September 2023.png
Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe
October 27, 2023 15:35 ET | Codexis, Inc.
REDWOOD CITY, Calif., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced a presentation highlighting the role of an enzymatic...
Codexis Logo - September 2023.png
Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe
October 26, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced a presentation highlighting the role of an enzymatic...
Codexis Logo - September 2023.png
Codexis to Report Third Quarter 2023 Financial Results on November 2
October 19, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the third...
Stephen Dilly Headshot
Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award
September 29, 2023 07:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced President and Chief Executive Officer Stephen Dilly,...
Stephen Dilly Headshot
Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award
September 18, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced Stephen Dilly, MBBS, PhD, President and Chief Executive...
CDXS Logo 2 April 2021.jpg
Codexis to Participate in Cantor Global Healthcare Conference
September 12, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Cantor Global Healthcare...
CDXS Logo 2 April 2021.jpg
Codexis Announces Agreement for Assignment and Assumption of San Carlos Facility Lease
September 07, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company has executed an Assignment and Assumption of...